Position Yourself as the Go-To Partner in AI/ML-Enabled Small Molecule Discovery

As the small molecule discovery space accelerates, aided by AI/ML powered approaches, developers are actively seeking innovative, reliable partners to support their discovery programs from target enablement, to hit identification and lead optimization. With more biopharma investing into AI/ML technologies, competition is growing, making it essential to stand out as the preferred partner of choice.

The AI Convergence: Small Molecule Discovery Summit offers you the unique opportunity to promote your capabilities, build brand recognition, and align yourself with the next wave of small molecule innovators.

Whether you are ready to showcase your services or looking to quietly scout the market and establish presence, being present ensures your name is noticed by key decision-makers across the biopharma landscape.

Identify how your team can best engage with the small molecule discovery community by joining the conversation, building strategic relationships, or positioning your services as a leader in the AI/ML-enabled small molecule discovery space.

Why Partner 1

Make Partnering Your Priority:

Meet New Clients & Collaborators

Expand your client base by networking face-to-face with dedicated attendees actively seeking solutions and partners to address their AI small molecule discovery challenges.

Centre Yourself in Biopharma Deal-Making

Build your brand awareness amongst C-suite decision-makers by showcasing your company logo on event materials including our website, brochure, and on-site signage.

Spotlight Your Expertise

Present your work to a targeted audience, co-lead a workshop or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.

Gain Market Intelligence

Stay ahead of latest industry trends and growth opportunities by hearing directly from key thought leaders. Access competitor insights and strategies to shape your organization’s future and sharpen its competitive edge.

Key Services & Solutions:

Our attendees from pharma, techbio, biotech and academia need service and solution providers with capabilities in, but not limited to, the below areas:

Innovative AI/ML models for generative molecular design to scope out untapped chemical space for novel small molecules

Novel computational services with predictive and simulation capabilities to complement AI/ML model insights

Advanced chemistry lab automation capabilities to streamline wet-lab experimental validation

Hardware and cloud compute power to support AI workloads in life sciences

Data as a service to manage, annotate and structure data for AI model training in life sciences

What Our Experts Have to Say:

OpenADMET - Attending Companies

Data is an essential component for any AI effort. This program brings together several efforts around the most critical components of AI and ML workflows

Pat Walters, Chief Scientist, OpenADMET,
2026 Speaker

Montai Therapeutics - Attending

It’s always great to learn more about how different people are solving challenges in drug discovery with state-of-the-art AI technologies, given how fast it is evolving

Hok Hei Tam, Co-Founder & Chief Technology Officer, Montai Therapeutics & Senior Principal, Flagship Pioneering, 2026 Speaker

Audience Composition:

Company Type

Companies Attending Graph - AI Convergence: Small Molecule Discovery

Attendee Seniority

Seniority of Attendees Graph - AI Convergence: Small Molecule Discovery

*Statistics Taken from the 10th Computational Drug Design for Biologics Summit

Attending Companies:

Bespoke Partnership Opportunities Available Include:

We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as badges and exclusive dinners to help elevate your brand.

Why Partner 3

Dedicated Presenting Sessions

Take up one of our prized presentations slots to spotlight data or case studies that position your alongside key thought-leaders.

Why Partner 4

Lead Expert Panels

Play your role in discussions shaping the very application of AI/ML approaches driving future small molecule discovery.

Why Partner 5

Full Delegate List

Gain exclusive access to the complete attendee list to strategically plan your conversations in advance.

Exhibit Your Capabilities - Why Partner

Exhibit Your Capabilities

Raise brand awareness and answer questions from prospect customers to place your services at the heart of small molecule discovery AI innovation.

Why Partner 7

Network & Exchange

Engage in 1-2-1 conversations with biopharma experts to generate commercial collaborations in 2026 and beyond.

Why Partner 8

Innovative Networking

Host breakfast, lunches, dinners or drinks receptions that offer exclusive time with your target audience.

Why Partner 9

Champion the Industry

Be part of the AI Convergence: Small Molecule Discovery Summit community and position yourself as an advocate for innovation and achievements in the space.

Why Partner 10

Brand Visibility

Opt for on-site and website branding to highlight your company at the forefront of the AI/ML-driven small molecule discovery field.

Get in Touch:

Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.

Tazeen Kapadia

Partnerships Director

Why Partner 6
Network With Decision-Makers

Speak with our audience of senior scientific experts during dedicated meeting breaks and structured networking opportunities.

Maintain Your Competitive Edge - Why Partner
Hear the Latest Breakthroughs

Participate in conversations with top biopharma experts to ensure your services are aligned with the needs of your clients.

Showcase Your Capabilities - Why Partner
Showcase Your Capabilities

Explore our bespoke sponsorship options including branding, presenting, and exhibiting to build a package tailored to you and your company's goals.